Remove Bioavailability Remove Medicine Remove Nurses
article thumbnail

Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration

XTalks

We know that a lot of different pathologies, especially as we’ve entered the era of molecular medicine and gene therapies, cause many of the same symptoms and work through final common pathways. Targeting the CNS directly has been successful in modern medicine. Next Steps for Targeted CNS Delivery. The patients are waiting!

Trials 83
article thumbnail

World Parkinson’s Day 2023 and Promising Parkinson’s Disease Treatments

XTalks

By avoiding the stomach entirely, there is increased bioavailability and more sustained relief from symptoms. Ambroxol is a cough medicine in the mucolytics family (thins and removes mucus from airways). ND0612 is currently in Phase III of clinical development and is supported by four years of safety data.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

ProstaStream

The Pharma Data

And the unique Japanese mushroom trio – Maitake, Reishi and Shiitake- which were proven to have incredible health properties by one study in the Journal of Oxidative Medicine and Cellular Longevity! If you are pregnant, nursing, taking medication, or have a medical condition, consult your physician before using our products.

article thumbnail

New Phase 3 Data Show TAK-620 (maribavir), an Investigational Drug for the Treatment of Transplant Recipients with Refractory/Resistant Cytomegalovirus (CMV) Infections, Meets Primary Endpoint

The Pharma Data

Food and Drug Administration and European Medicines Agency as we work to bring maribavir to patients.”. Maribavir, an orally bioavailable anti-CMV compound, is the only antiviral agent presently in Phase 3 development for the treatment of post-transplant patients with CMV in SOT or HSCT. About Maribavir. 2017;17:856-879.

Drugs 52